Suppr超能文献

[人类免疫缺陷病毒1型病毒载量和CD4淋巴细胞计数作为艾滋病进展和生存决定因素的价值]

[Value of HIV-1 viral load and CD4 lymphocyte count as determinants of progression to AIDS and survival].

作者信息

Romeu J, Balagué M, Ruiz L, Marfil S, Puig T, Arnó A, Veny A, Tural C, Sirera G, Clotet B

机构信息

Hospital de Día VIH (Servicio de Medicina Interna, Badalona, Barcelona.

出版信息

Med Clin (Barc). 1998 Jun 6;110(20):761-7.

PMID:9666416
Abstract

BACKGROUND

HIV-1 viral load is regarded as a better surrogate marker for progression and death than CD4+ cell counts. Both markers are analysed in a cohort of patients with unknown seroconversion date and advanced HIV infection.

PATIENTS AND METHODS

Retrospective cohort analysis of 421 patients, most on antiretroviral therapy, with a median initial CD4+ cell count of 209 x 10(6)/l and a median initial viral load of 4.7 log copies/ml. One thousand two hundred and eighty-six samples were analysed. Univariate and bivariate analysis were performed with initial and sequential CD4+ cell counts and viral load values to estimate the risk of progression and death by Cox regression models.

RESULTS

After a median follow up of 763 days, 124 patients developed AIDS and 117 died. Relative risks of progression related to the group that maintained viral load values always < 35,000 copies/ml were: 5-fold (95% CI: 1.4-17.0; p < 0.05) for patients with any viral load value > 35,000 copies/ml but always < 200,000 copies/ml; and 13.6 fold (95% CI: 5.4-34.2; p < 0.0001) for patients who could not maintain viral load < 200.000 copies/ml. CD4+ counts = 100 x 10(6)/l and viral load = 220,000 copies/ml were the threshold values that best fitted to estimate the probability of survival by a bivariate analysis.

CONCLUSIONS

The maintenance of sequential viral load values < 35.000 copies/ml is associated with a lower risk of progression. The maintenance of sequential viral load values < 150,000 copies/ml is associated with higher short-term survival rates.

摘要

背景

与CD4+细胞计数相比,HIV-1病毒载量被认为是疾病进展和死亡的更好替代指标。在一组血清转化日期不明且患有晚期HIV感染的患者中对这两个指标进行了分析。

患者和方法

对421例患者进行回顾性队列分析,大多数患者接受抗逆转录病毒治疗,初始CD4+细胞计数中位数为209×10⁶/l,初始病毒载量中位数为4.7 log拷贝/ml。共分析了1286份样本。使用初始和连续的CD4+细胞计数及病毒载量值进行单变量和双变量分析,通过Cox回归模型估计疾病进展和死亡风险。

结果

中位随访763天后,124例患者发展为艾滋病,117例死亡。与病毒载量值始终< 35,000拷贝/ml的组相比,进展的相对风险为:任何病毒载量值> 35,000拷贝/ml但始终< 200,000拷贝/ml的患者为5倍(95%CI:1.4 - 17.0;p<0.05);无法将病毒载量维持在< 200,000拷贝/ml的患者为13.6倍(95%CI:5.4 - 34.2;p<0.0001)。CD4+计数 = 100×10⁶/l和病毒载量 = 220,000拷贝/ml是通过双变量分析最适合估计生存概率的阈值。

结论

连续病毒载量值维持在< 35,000拷贝/ml与较低的疾病进展风险相关。连续病毒载量值维持在< 150,000拷贝/ml与较高的短期生存率相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验